…
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. It has strategic partnership agreements with TriHealth, Prisma Health, and the University Health System of San Antonio to help the health system standardize patient monitoring, drive interoperability, and lay the foundation for enterprise-wide platform; and Oulu University Hospital to deliver advanced image-guided therapy solutions. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | -1731.00M | 509.00M | 1490.00M | 1529.00M | 1503.00M |
| Minority interest | -3.00M | -4.00M | 31.00M | 28.00M | 29.00M |
| Net income | -1618.00M | 612.00M | 1187.00M | 1168.00M | 1090.00M |
| Selling general administrative | 671.00M | 599.00M | 668.00M | 631.00M | 631.00M |
| Selling and marketing expenses | 4609.00M | 4258.00M | 4606.00M | 4682.00M | 4500.00M |
| Gross profit | 7194.00M | 7168.00M | 8781.00M | 8875.00M | 8553.00M |
| Reconciled depreciation | 1602.00M | 1323.00M | 1520.00M | 1402.00M | 1089.00M |
| Ebit | -116.00M | 553.00M | 1542.00M | 1644.00M | 1767.00M |
| Ebitda | 1486.00M | 2020.00M | 3214.00M | 3164.00M | 2856.00M |
| Depreciation and amortization | 1602.00M | 1467.00M | 1672.00M | 1520.00M | 1089.00M |
| Non operating income net other | - | - | - | 0.00M | 0.00M |
| Operating income | -116.00M | 553.00M | 1542.00M | 1644.00M | 1719.00M |
| Other operating expenses | 17998.00M | 16603.00M | 17993.00M | 17837.00M | 16403.00M |
| Interest expense | 258.00M | 188.00M | 204.00M | 233.00M | 264.00M |
| Tax provision | -113.00M | -103.00M | 284.00M | 337.00M | 193.00M |
| Interest income | 58.00M | 149.00M | 160.00M | 69.00M | 154.00M |
| Net interest income | -200.00M | -39.00M | -44.00M | -164.00M | -204.00M |
| Extraordinary items | 13.00M | 2711.00M | -10.00M | -19.00M | -213.00M |
| Non recurring | - | - | - | 0.00M | 0.00M |
| Other items | - | - | - | 0.00M | 0.00M |
| Income tax expense | -113.00M | -103.00M | 284.00M | 337.00M | 193.00M |
| Total revenue | 17827.00M | 17156.00M | 19535.00M | 19482.00M | 18121.00M |
| Total operating expenses | 7365.00M | 6615.00M | 7239.00M | 7230.00M | 6835.00M |
| Cost of revenue | 10633.00M | 9988.00M | 10754.00M | 10607.00M | 9568.00M |
| Total other income expense net | -1615.00M | -44.00M | -52.00M | -115.00M | -2.00M |
| Discontinued operations | 13.00M | 2711.00M | -10.00M | -19.00M | -213.00M |
| Net income from continuing ops | -1618.00M | 612.00M | 1205.00M | 1192.00M | 1310.00M |
| Net income applicable to common shares | -1608.00M | 3319.00M | 1187.00M | 1167.00M | 1090.00M |
| Preferred stock and other adjustments | - | - | - | 0.00M | 0.00M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Total assets | 30688.00M | 30961.00M | 27713.00M | 26983.00M | 26019.00M |
| Intangible assets | 3526.00M | 3650.00M | 2997.00M | 3466.00M | 3589.00M |
| Other current assets | 490.00M | 493.00M | 424.00M | 477.00M | 469.00M |
| Total liab | 17405.00M | 16487.00M | 15812.00M | 14358.00M | 13902.00M |
| Total stockholder equity | 13249.00M | 14438.00M | 11870.00M | 12597.00M | 12088.00M |
| Deferred long term liab | 393.00M | 598.00M | 621.00M | 592.00M | 620.00M |
| Other current liab | 3339.00M | 3581.00M | 3149.00M | 3178.00M | 3368.00M |
| Common stock | 178.00M | 177.00M | 182.00M | 179.00M | 185.00M |
| Capital stock | 178.00M | 177.00M | 182.00M | 179.00M | 185.00M |
| Retained earnings | 6832.00M | 9344.00M | 7827.00M | 8296.00M | 8266.00M |
| Other liab | 2201.00M | 2564.00M | 2372.00M | 2474.00M | 2532.00M |
| Good will | 10238.00M | 10637.00M | 8014.00M | 8654.00M | 8503.00M |
| Other assets | 2551.00M | 1.00M | 2744.00M | 2682.00M | 2862.00M |
| Cash | 1172.00M | 2303.00M | 3226.00M | 1425.00M | 1688.00M |
| Cash and equivalents | 1172.00M | 2303.00M | 3226.00M | 1425.00M | 1688.00M |
| Total current liabilities | 7934.00M | 7450.00M | 7736.00M | 6945.00M | 7943.00M |
| Current deferred revenue | 1696.00M | 1491.00M | 1239.00M | 1170.00M | 878.00M |
| Net debt | 7029.00M | 4676.00M | 3708.00M | 4022.00M | 3133.00M |
| Short term debt | 931.00M | 506.00M | 1229.00M | 508.00M | 1394.00M |
| Short long term debt | 931.00M | 506.00M | 1229.00M | 110.00M | 1306.00M |
| Short long term debt total | 8201.00M | 6979.00M | 6934.00M | 5447.00M | 4821.00M |
| Other stockholder equity | 4751.00M | 13513.00M | 12028.00M | 11766.00M | 26428.00M |
| Property plant equipment | 2638.00M | 2699.00M | 2682.00M | 2866.00M | 1509.00M |
| Total current assets | 10259.00M | 10347.00M | 11227.00M | 9439.00M | 9572.00M |
| Long term investments | 1197.00M | 1056.00M | 670.00M | 481.00M | 558.00M |
| Net tangible assets | -122.00M | 151.00M | 1480.00M | 1069.00M | 616.00M |
| Short term investments | 11.00M | 2.00M | 0.00M | 1.00M | 436.00M |
| Net receivables | 4337.00M | 3967.00M | 4306.00M | 4712.00M | 4182.00M |
| Long term debt | 7270.00M | 6473.00M | 5705.00M | 3768.00M | 3003.00M |
| Inventory | 4049.00M | 3450.00M | 2993.00M | 2773.00M | 2674.00M |
| Accounts payable | 1968.00M | 1872.00M | 2119.00M | 2089.00M | 2303.00M |
| Total permanent equity | - | - | - | 0.00M | 0.00M |
| Noncontrolling interest in consolidated entity | - | - | - | 0.00M | 0.00M |
| Temporary equity redeemable noncontrolling interests | - | - | - | 0.00M | 0.00M |
| Accumulated other comprehensive income | 1488.00M | 748.00M | -340.00M | 652.00M | 11903.00M |
| Additional paid in capital | - | - | - | 0.00M | 0.00M |
| Common stock total equity | - | - | 182.00M | 0.00M | 0.00M |
| Preferred stock total equity | - | - | - | 0.00M | 0.00M |
| Retained earnings total equity | - | - | - | 0.00M | 0.00M |
| Treasury stock | - | -476.00M | -199.00M | -201.00M | -399.00M |
| Accumulated amortization | - | - | - | 0.00M | 0.00M |
| Non currrent assets other | 381.00M | 355.00M | 303.00M | 226.00M | 211.00M |
| Deferred long term asset charges | - | - | - | 0.00M | 0.00M |
| Non current assets total | 20429.00M | 20613.00M | 16486.00M | 17544.00M | 16447.00M |
| Capital lease obligations | 1082.00M | 1220.00M | 1215.00M | 1381.00M | 236.00M |
| Long term debt total | 7018.00M | 6473.00M | 5705.00M | 4877.00M | 3239.00M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | -1487.00M | -3672.00M | -1316.00M | -603.00M | -1486.00M |
| Change to liabilities | 52.00M | 219.00M | 411.00M | -369.00M | 311.00M |
| Total cashflows from investing activities | -1487.00M | -3672.00M | -1316.00M | -603.00M | -1486.00M |
| Net borrowings | 1091.00M | -251.00M | 783.00M | 109.00M | 160.00M |
| Total cash from financing activities | 500.00M | -2347.00M | 483.00M | -1665.00M | -1192.00M |
| Change to operating activities | -282.00M | 414.00M | -47.00M | 149.00M | -320.00M |
| Net income | -1618.00M | 612.00M | 1205.00M | 1192.00M | 1310.00M |
| Change in cash | -1131.00M | -923.00M | 1801.00M | -263.00M | -251.00M |
| Begin period cash flow | 2303.00M | 3226.00M | 1425.00M | 1688.00M | 1939.00M |
| End period cash flow | 1172.00M | 2303.00M | 3226.00M | 1425.00M | 1688.00M |
| Total cash from operating activities | -173.00M | 1629.00M | 2777.00M | 2031.00M | 1780.00M |
| Issuance of capital stock | 12.00M | 23.00M | 46.00M | 58.00M | 94.00M |
| Depreciation | 1602.00M | 1323.00M | 1520.00M | 1402.00M | 1089.00M |
| Other cashflows from investing activities | -681.00M | 49.00M | -13.00M | 385.00M | -174.00M |
| Dividends paid | 412.00M | 482.00M | 1.00M | 453.00M | 401.00M |
| Change to inventory | -572.00M | -581.00M | -584.00M | -175.00M | -394.00M |
| Change to account receivables | -342.00M | -39.00M | 87.00M | -274.00M | -97.00M |
| Sale purchase of stock | -187.00M | -1636.00M | -343.00M | -1376.00M | -1042.00M |
| Other cashflows from financing activities | 2559.00M | 50.00M | 1079.00M | 867.00M | 1318.00M |
| Change to netincome | 1292.00M | 432.00M | 392.00M | 319.00M | 748.00M |
| Capital expenditures | 806.00M | 763.00M | 942.00M | 1013.00M | 843.00M |
| Change receivables | - | - | - | 0.00M | 0.00M |
| Cash flows other operating | - | - | - | 0.00M | 0.00M |
| Exchange rate changes | - | - | - | 0.00M | 0.00M |
| Cash and cash equivalents changes | - | - | - | 0.00M | 0.00M |
| Change in working capital | -1144.00M | 13.00M | -133.00M | -669.00M | -500.00M |
| Stock based compensation | 95.00M | 108.00M | 115.00M | 98.00M | -485.00M |
| Other non cash items | 1005.00M | -324.00M | -214.00M | -329.00M | 173.00M |
| Free cash flow | -979.00M | 866.00M | 1835.00M | 1018.00M | 937.00M |
Sector: Healthcare Industry: Medical Devices
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| PHG Koninklijke Philips NV ADR |
-0.16 0.52% |
30.35 | - | 14.29 | 1.14 | 1.58 | 1.58 | -308.94 |
| ABT Abbott Laboratories |
-0.03 0.03% |
109.93 | 25.97 | 17.24 | 3.57 | 3.20 | 3.81 | 16.75 |
| MDT Medtronic PLC |
-3.04 2.90% |
101.80 | 26.60 | 15.87 | 3.35 | 2.08 | 3.90 | 14.12 |
| SYK Stryker Corporation |
-9.21 2.75% |
325.87 | 29.23 | 16.86 | 4.18 | 4.51 | 4.63 | 17.16 |
| SEMHF Siemens Healthineers AG |
-2.15 4.12% |
49.85 | 39.57 | 21.32 | 3.01 | 3.29 | 2.95 | 16.92 |
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. It has strategic partnership agreements with TriHealth, Prisma Health, and the University Health System of San Antonio to help the health system standardize patient monitoring, drive interoperability, and lay the foundation for enterprise-wide platform; and Oulu University Hospital to deliver advanced image-guided therapy solutions. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
| Name | Title | Year Born |
|---|---|---|
| Dr. Paulus A. Stoffels M.D., Ph.D. | Independent Vice Chairman of Supervisory Board & Sec. | 1962 |
| Mr. Abhijit Bhattacharya | Exec. VP, CFO & Member of the Board of Management | 1961 |
| Mr. Marnix J. van Ginneken | Exec. VP, Chief Legal Officer & Member of the Board of Management | 1973 |
| Mr. François Adrianus van Houten | Advisor | 1960 |
| Mr. Roy Jakobs | CEO & Pres | 1974 |
| Mr. Willem Appelo | Chief Operations Officer | 1965 |
| Mr. Leandro Mazzoni | Head of Investor Relations | NA |
| Ms. Daniela Seabrook | Exec. VP & Chief HR Officer | 1973 |
| Mr. Sean Carney | Chief Design Officer | NA |
| Mr. Jeroen Tas | Exec. Officer | 1959 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.